Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01471210
Brief Title: Safety, Tolerability, Pharmacokinetics, and Immunoregulatory Study of Urelumab (BMS-663513) in Subjects With Advanced and/or Metastatic Solid Tumors and Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

First Submitted : November 10, 2011
First Submitted that Met QC Criteria : November 14, 2011
First Posted : November 15, 2011 (Estimate)

Last Update Submitted that Met QC Criteria : April 17, 2017
Last Update Posted : April 19, 2017